Ayat Majeed Zeadan

Ayat Majeed Zeadan

Auto-generated profile, based on publicly available information

Ayat Majeed Zeadan

Microbiology department Collage of medicine Aliraqia University Baghdad Iraq

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2025 in SHIFAA
Verified
Journal Article
Open access
PDF file
SDSafiya Saad Dhaif
Safiya Saad Dhaif
HAHanan Al-Naymi
Hanan Al-Naymi
AHAshjan Mohammed Hussain
Ashjan Mohammed Hussain
TATareq Hafdi Abdtawfeeq
Tareq Hafdi Abdtawfeeq
AZAyat Majeed Zeadan
Ayat Majeed Zeadan
NINathier A. Ibrahim
Nathier A. Ibrahim
Diabetes, a chronic metabolic disorder and silent killer, results from insufficient insulin production or utilization, leading to systemic complications. This study integrates global diabetes data with a local sample from the National Diabetes Center, Mustansiriyah University (Baghdad, Iraq) to provide a comparative perspective. Global data from the *International Diabetes Federation* and *IHME Global Burden of Disease* were analyzed and visualized. Additionally, 50 diabetic patients under treatment and follow-up at the National Center were statistically evaluated using paired sample t-tests in SPSS. Worldwide, diabetes cases reached 536.6 million and are projected to rise to 783.2 million by 2045 (+46%). Undiagnosed cases (239.7 million) and deaths (7.1 million, +71% since 2011) were concentrated in the Western Pacific. Locally, paired t-test results (t = 7.73, t = 8.49, p < 0.001) confirmed significant differences pre- and post-intervention, indicating strong treatment response. By integrating global trends with local patient data, this study highlights the dual challenge of rising prevalence and underdiagnosis worldwide, contrasted with evidence of effective treatment outcomes at a local specialized center.

30 August 2024 in Journal of Medical and Oral Biosciences
Verified
Journal Article
Open access
AZAyat Majeed Zeadan
Ayat Majeed Zeadan
AQAlyaa Jabbar Qasim
Alyaa Jabbar Qasim
Uterine Cervical Carcinoma (UCC) is the most commongynecological malignancy internationally, with a rising incidence in recent years. Accumulating data indicates that specific viral infections, especially that are caused by oncogenic viruses including Epstein-Barr virus (EBV) that may contribute to UCC development in addition to progression. Understanding the complex interplay between EBV infections and UCC risk is crucial for developing novel preventative and therapeutic interventions.Consequently, this review study intends to explain the relationship between the occurrence of UCC and Epstein-Barr virus infection.

26 August 2025 in Journal of Medical and Oral Biosciences
Verified
Journal Article
Open access
AQAlyaa Jabbar Qasim
Alyaa Jabbar Qasim
ZAZainab A. A. Al-Shammary
Zainab A. A. Al-Shammary
ZMZahraa M. Mosa
Zahraa M. Mosa
HJHamza Jabbar Jabour
Hamza Jabbar Jabour
AZAyat Majeed Zeadan
Ayat Majeed Zeadan
The emergence of antibiotic-resistant bacteria associated with skin cancer infections poses a significant therapeutic challenge. This study synthesized silver nanoparticles (AgNPs) and amoxicillin-loaded silver nanoparticles (ALNPs) using a cost-effective chemical reduction method. UV–Vis spectroscopy confirmed nanoparticle formation and stability, with ALNPs showing complete encapsulation of amoxicillin. Antibacterial activity was assessed against Staphylococcus aureus and Pseudomonas aeruginosa using the disc diffusion method with triplicate experiments (n=3). Minimal inhibitory concentration (MIC) results indicated that ALNPs were effective at lower concentrations than free amoxicillin. S. aureus was inhibited by ALNPs at 0.6 mg/mL compared to 5 mg/mL for free amoxicillin, while P. aeruginosa responded to ALNPs at 5 mg/mL and was resistant to free amoxicillin. Statistical analysis (ANOVA, p<0.05) confirmed significant improvement in antibacterial efficacy for ALNPs. These results suggest that nanoparticle-mediated delivery of amoxicillin enhances its antibacterial potency and may provide a promising strategy to overcome partial resistance in skin cancer-associated infections.

18 July 2026
Verified
Book Chapter
Closed access
PDF file
Tarek MoussaTarek Moussa
Tarek Moussa
NSNevien M. Sabry
Nevien M. Sabry
AZAyat M. Zedan
Ayat M. Zedan
RHRehab Hafez
Rehab Hafez
CRISPR technology has transformed our comprehension of genetics, biotechnology, medicine, and molecular biology. Originating from bacterial immunity, CRISPR significantly enhances the capability to modify genetic materials. The emergence of CRISPR–Cas9 has created new opportunities for research and therapeutic uses. CRISPR technology facilitates accurate modifications to the genome, including gene knockouts, insertions, and repairs. Applications encompass fundamental research, agriculture, and prospective therapeutics for genetic abnormalities. Variants of the technology, such as CRISPR–Cas12 and CRISPR–Cas13, are expanding their capabilities, enabling precise RNA editing and other innovative applications. As research progresses, the potential of CRISPR–based technologies is expected to grow, providing new insights into significant difficulties in biology and medicine. This chapter delineates the discovery, advancement, and uses of CRISPR–Cas systems. We examine the history, function, and structure of CRISPR–Cas, along with its categorization and effector complexes. Furthermore, we investigate CRISPR–Cas systems within microbiomes and CRISPR-based gene-editing technologies.

30 August 2024 in Journal of Medical and Oral Biosciences
Verified
Journal Article
Open access
AQAlyaa Jabbar Qasim
Alyaa Jabbar Qasim
AZAyat Majeed Zeadan
Ayat Majeed Zeadan
SASura Mouaid Abbas
Sura Mouaid Abbas
Uterine Cervical Carcinoma (UCC) is the most common gynecological malignancy internationally, with a rising incidence in recent years. Accumulating data indicates that specific viral infections, especially that are caused by oncogenic viruses including Epstein-Barr virus (EBV) that may contribute to UCC development in addition to progression. Understanding the complex interplay between EBV infections and UCC risk is crucial for developing novel preventative and therapeutic interventions. Therefore, this review study focuses on the human papillomavirus (HPV) infection and the etiology of Uterine Cervical Carcinoma.